en
Groundbreaking research conducted at Queen’s University Belfast’s School of Pharmacy and the Centre for Infection and Immunity has led to new knowledge about cystic fibrosis (CF) that is being applied to patient care.
This video, produced by Video Services at QUB, explains new clinical trials where CF patients are participating in a clinical study aimed at bringing medicines and treatments to people faster. An important recent finding was that the lungs of people with CF are host to many different types of bacteria. The team are working to identify which ones may cause problems for people with CF. As part of this identification project, patient samples are processed in the laboratory in anaerobic workstations (the video shows staff using Whitley A35 and A45 Workstations).
The university is also working on better ways of delivering drugs to CF lungs, including the use of nanoparticles.
English